Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 10, 2014 - Issue
Submit an article Journal homepage
102
Views
5
CrossRef citations to date
0
Altmetric
Review

Clinical utility of orally disintegrating olanzapine in Chinese patients with schizophrenia: a review of effectiveness, patient preference, adherence, and other properties

Jingping Zhao1 Mental Health Institute of The Second Xiangya Hospital, Hunan Province Technology Institute of Psychiatry, Key Laboratory of Psychiatry and Mental Health of Hunan Province, Central South University, Changsha, Hunan, People’s Republic of ChinaCorrespondence[email protected]
,
Jianjun Ou1 Mental Health Institute of The Second Xiangya Hospital, Hunan Province Technology Institute of Psychiatry, Key Laboratory of Psychiatry and Mental Health of Hunan Province, Central South University, Changsha, Hunan, People’s Republic of China
,
Haibo Xue2 Lilly Suzhou Pharmaceutical Co, Ltd, Jiangsu, People’s Republic of China
,
Li Liu2 Lilly Suzhou Pharmaceutical Co, Ltd, Jiangsu, People’s Republic of China
,
William Montgomery3 Global Health Outcomes, Eli Lilly and Company, Sydney, Australia
&
Tamas Treuer4 Emerging Markets Business Unit (Neuroscience), Eli Lilly and Company, Budapest, Hungary
Pages 355-359 | Published online: 19 Feb 2014

Figures & data

Figure 1 Publication flow diagram.

Figure 1 Publication flow diagram.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.